Silvia Bagnoli

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 119 publications

Plasma p-tau217 best captures early longitudinal cognitive changes in subjective cognitive decline compared with p-tau181 and NfL.

Plasma p-tau217 best captures early longitudinal cognitive changes in subjective cognitive decline compared with p-tau181 and NfL.

Journal: Journal of neurology

Published: May 21, 2026

Cumulative Incidence in Monogenic Alzheimer's Disease and Frontotemporal Dementia: Gene-Gene Interaction Effect.

Cumulative Incidence in Monogenic Alzheimer's Disease and Frontotemporal Dementia: Gene-Gene Interaction Effect.

Journal: International journal of molecular sciences

Published: March 05, 2026

Towards the development of a management protocol for subjective cognitive decline: Insights from a cross-sectional and longitudinal analysis of multimodal data from a memory clinic.

Towards the development of a management protocol for subjective cognitive decline: Insights from a cross-sectional and longitudinal analysis of multimodal data from a memory clinic.

Journal: Journal of Alzheimer's disease : JAD

Published: January 28, 2026

Refining Alzheimer's disease biological diagnosis with plasma biomarkers: Resolving p-tau217 "gray zone" with p-tau181 integration.

Refining Alzheimer's disease biological diagnosis with plasma biomarkers: Resolving p-tau217 "gray zone" with p-tau181 integration.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: November 09, 2025

Correction: Open-label evaluation of oral trehalose in patients with neuronal ceroid lipofuscinoses.

Correction: Open-label evaluation of oral trehalose in patients with neuronal ceroid lipofuscinoses.

Journal: Journal of neurology

Published: October 15, 2025

Miglustat does not impact clinical progression in patients with spastic paraplegia type 11.

Miglustat does not impact clinical progression in patients with spastic paraplegia type 11.

Journal: Neurogenetics

Published: August 28, 2025

Plasma p-tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study.

Plasma p-tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study.

Journal: Annals of clinical and translational neurology

Published: July 01, 2025

The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer's disease.

The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer's disease.

Journal: Journal of neurology

Published: June 25, 2025

Beyond language: empathy and emotion recognition deficits in primary progressive aphasias.

Beyond language: empathy and emotion recognition deficits in primary progressive aphasias.

Journal: NeuroImage. Clinical

Published: May 07, 2025

Protective TMEM106B-rs3173615 delays age at onset in GRN mutation carriers.

Protective TMEM106B-rs3173615 delays age at onset in GRN mutation carriers.

Journal: Molecular psychiatry

Published: April 29, 2025

Gender differences in cognitive reserve: An impact on progression in subjective cognitive decline?

Gender differences in cognitive reserve: An impact on progression in subjective cognitive decline?

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: April 10, 2025

Evaluation of Illumina and Oxford Nanopore Sequencing for the Study of DNA Methylation in Alzheimer's Disease and Frontotemporal Dementia.

Evaluation of Illumina and Oxford Nanopore Sequencing for the Study of DNA Methylation in Alzheimer's Disease and Frontotemporal Dementia.

Journal: International journal of molecular sciences

Published: February 27, 2025

Showing 1-12 of 119

Last Updated: 09/26/2026